0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral Anti-allergic Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-13O14163
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oral Anti allergic Drugs Market Research Report 2023
BUY CHAPTERS

Global Oral Anti-allergic Drugs Market Research Report 2025

Code: QYRE-Auto-13O14163
Report
May 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oral Anti-allergic Drugs Market Size

The global market for Oral Anti-allergic Drugs was valued at US$ 29690 million in the year 2024 and is projected to reach a revised size of US$ 38410 million by 2031, growing at a CAGR of 3.8% during the forecast period.

Oral Anti-allergic Drugs Market

Oral Anti-allergic Drugs Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Anti-allergic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Anti-allergic Drugs.
The Oral Anti-allergic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Anti-allergic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Anti-allergic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oral Anti-allergic Drugs Market Report

Report Metric Details
Report Name Oral Anti-allergic Drugs Market
Accounted market size in year US$ 29690 million
Forecasted market size in 2031 US$ 38410 million
CAGR 3.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Johnson & Johnson, Merck, Teva, GlaxoSmithKline, Bayer, Almirall, Pfizer, AstraZeneca, Sun Pharma, Novartis, Boehringer Ingelheim, UCB Pharma, Yangtze River Pharmaceutical Group, Hainan Poly Pharm, Chongqing Huapont Pharmaceutical, Dawnrays Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oral Anti-allergic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oral Anti-allergic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Oral Anti-allergic Drugs Market growing?

Ans: The Oral Anti-allergic Drugs Market witnessing a CAGR of 3.8% during the forecast period 2025-2031.

What is the Oral Anti-allergic Drugs Market size in 2031?

Ans: The Oral Anti-allergic Drugs Market size in 2031 will be US$ 38410 million.

Who are the main players in the Oral Anti-allergic Drugs Market report?

Ans: The main players in the Oral Anti-allergic Drugs Market are Sanofi, Johnson & Johnson, Merck, Teva, GlaxoSmithKline, Bayer, Almirall, Pfizer, AstraZeneca, Sun Pharma, Novartis, Boehringer Ingelheim, UCB Pharma, Yangtze River Pharmaceutical Group, Hainan Poly Pharm, Chongqing Huapont Pharmaceutical, Dawnrays Pharma

What are the Application segmentation covered in the Oral Anti-allergic Drugs Market report?

Ans: The Applications covered in the Oral Anti-allergic Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Oral Anti-allergic Drugs Market report?

Ans: The Types covered in the Oral Anti-allergic Drugs Market report are Antihistamine Drugs, Allergic Mediator Release Agent, Immunosuppressant Drugs

Recommended Reports

Anti-allergy & Rhinitis

Antihistamines & Allergy

Oral Drug Therapeutics

1 Oral Anti-allergic Drugs Market Overview
1.1 Product Definition
1.2 Oral Anti-allergic Drugs by Type
1.2.1 Global Oral Anti-allergic Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Antihistamine Drugs
1.2.3 Allergic Mediator Release Agent
1.2.4 Immunosuppressant Drugs
1.3 Oral Anti-allergic Drugs by Application
1.3.1 Global Oral Anti-allergic Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Oral Anti-allergic Drugs Market Size Estimates and Forecasts
1.4.1 Global Oral Anti-allergic Drugs Revenue 2020-2031
1.4.2 Global Oral Anti-allergic Drugs Sales 2020-2031
1.4.3 Global Oral Anti-allergic Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oral Anti-allergic Drugs Market Competition by Manufacturers
2.1 Global Oral Anti-allergic Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Oral Anti-allergic Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Oral Anti-allergic Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oral Anti-allergic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Anti-allergic Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Anti-allergic Drugs, Product Type & Application
2.7 Global Key Manufacturers of Oral Anti-allergic Drugs, Date of Enter into This Industry
2.8 Global Oral Anti-allergic Drugs Market Competitive Situation and Trends
2.8.1 Global Oral Anti-allergic Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oral Anti-allergic Drugs Players Market Share by Revenue
2.8.3 Global Oral Anti-allergic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral Anti-allergic Drugs Market Scenario by Region
3.1 Global Oral Anti-allergic Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oral Anti-allergic Drugs Sales by Region: 2020-2031
3.2.1 Global Oral Anti-allergic Drugs Sales by Region: 2020-2025
3.2.2 Global Oral Anti-allergic Drugs Sales by Region: 2026-2031
3.3 Global Oral Anti-allergic Drugs Revenue by Region: 2020-2031
3.3.1 Global Oral Anti-allergic Drugs Revenue by Region: 2020-2025
3.3.2 Global Oral Anti-allergic Drugs Revenue by Region: 2026-2031
3.4 North America Oral Anti-allergic Drugs Market Facts & Figures by Country
3.4.1 North America Oral Anti-allergic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oral Anti-allergic Drugs Sales by Country (2020-2031)
3.4.3 North America Oral Anti-allergic Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Anti-allergic Drugs Market Facts & Figures by Country
3.5.1 Europe Oral Anti-allergic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oral Anti-allergic Drugs Sales by Country (2020-2031)
3.5.3 Europe Oral Anti-allergic Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Anti-allergic Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Oral Anti-allergic Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oral Anti-allergic Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Oral Anti-allergic Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Anti-allergic Drugs Market Facts & Figures by Country
3.7.1 Latin America Oral Anti-allergic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oral Anti-allergic Drugs Sales by Country (2020-2031)
3.7.3 Latin America Oral Anti-allergic Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Anti-allergic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Anti-allergic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oral Anti-allergic Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oral Anti-allergic Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Anti-allergic Drugs Sales by Type (2020-2031)
4.1.1 Global Oral Anti-allergic Drugs Sales by Type (2020-2025)
4.1.2 Global Oral Anti-allergic Drugs Sales by Type (2026-2031)
4.1.3 Global Oral Anti-allergic Drugs Sales Market Share by Type (2020-2031)
4.2 Global Oral Anti-allergic Drugs Revenue by Type (2020-2031)
4.2.1 Global Oral Anti-allergic Drugs Revenue by Type (2020-2025)
4.2.2 Global Oral Anti-allergic Drugs Revenue by Type (2026-2031)
4.2.3 Global Oral Anti-allergic Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Oral Anti-allergic Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oral Anti-allergic Drugs Sales by Application (2020-2031)
5.1.1 Global Oral Anti-allergic Drugs Sales by Application (2020-2025)
5.1.2 Global Oral Anti-allergic Drugs Sales by Application (2026-2031)
5.1.3 Global Oral Anti-allergic Drugs Sales Market Share by Application (2020-2031)
5.2 Global Oral Anti-allergic Drugs Revenue by Application (2020-2031)
5.2.1 Global Oral Anti-allergic Drugs Revenue by Application (2020-2025)
5.2.2 Global Oral Anti-allergic Drugs Revenue by Application (2026-2031)
5.2.3 Global Oral Anti-allergic Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Oral Anti-allergic Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Oral Anti-allergic Drugs Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Oral Anti-allergic Drugs Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Oral Anti-allergic Drugs Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Teva
6.4.1 Teva Company Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Oral Anti-allergic Drugs Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Company Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GlaxoSmithKline Oral Anti-allergic Drugs Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Company Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bayer Oral Anti-allergic Drugs Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Almirall
6.7.1 Almirall Company Information
6.7.2 Almirall Description and Business Overview
6.7.3 Almirall Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Almirall Oral Anti-allergic Drugs Product Portfolio
6.7.5 Almirall Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer Oral Anti-allergic Drugs Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Company Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AstraZeneca Oral Anti-allergic Drugs Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Sun Pharma
6.10.1 Sun Pharma Company Information
6.10.2 Sun Pharma Description and Business Overview
6.10.3 Sun Pharma Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sun Pharma Oral Anti-allergic Drugs Product Portfolio
6.10.5 Sun Pharma Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Company Information
6.11.2 Novartis Description and Business Overview
6.11.3 Novartis Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Novartis Oral Anti-allergic Drugs Product Portfolio
6.11.5 Novartis Recent Developments/Updates
6.12 Boehringer Ingelheim
6.12.1 Boehringer Ingelheim Company Information
6.12.2 Boehringer Ingelheim Description and Business Overview
6.12.3 Boehringer Ingelheim Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Boehringer Ingelheim Oral Anti-allergic Drugs Product Portfolio
6.12.5 Boehringer Ingelheim Recent Developments/Updates
6.13 UCB Pharma
6.13.1 UCB Pharma Company Information
6.13.2 UCB Pharma Description and Business Overview
6.13.3 UCB Pharma Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 UCB Pharma Oral Anti-allergic Drugs Product Portfolio
6.13.5 UCB Pharma Recent Developments/Updates
6.14 Yangtze River Pharmaceutical Group
6.14.1 Yangtze River Pharmaceutical Group Company Information
6.14.2 Yangtze River Pharmaceutical Group Description and Business Overview
6.14.3 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Product Portfolio
6.14.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
6.15 Hainan Poly Pharm
6.15.1 Hainan Poly Pharm Company Information
6.15.2 Hainan Poly Pharm Description and Business Overview
6.15.3 Hainan Poly Pharm Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Hainan Poly Pharm Oral Anti-allergic Drugs Product Portfolio
6.15.5 Hainan Poly Pharm Recent Developments/Updates
6.16 Chongqing Huapont Pharmaceutical
6.16.1 Chongqing Huapont Pharmaceutical Company Information
6.16.2 Chongqing Huapont Pharmaceutical Description and Business Overview
6.16.3 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Product Portfolio
6.16.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
6.17 Dawnrays Pharma
6.17.1 Dawnrays Pharma Company Information
6.17.2 Dawnrays Pharma Description and Business Overview
6.17.3 Dawnrays Pharma Oral Anti-allergic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Dawnrays Pharma Oral Anti-allergic Drugs Product Portfolio
6.17.5 Dawnrays Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Anti-allergic Drugs Industry Chain Analysis
7.2 Oral Anti-allergic Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Anti-allergic Drugs Production Mode & Process Analysis
7.4 Oral Anti-allergic Drugs Sales and Marketing
7.4.1 Oral Anti-allergic Drugs Sales Channels
7.4.2 Oral Anti-allergic Drugs Distributors
7.5 Oral Anti-allergic Drugs Customer Analysis
8 Oral Anti-allergic Drugs Market Dynamics
8.1 Oral Anti-allergic Drugs Industry Trends
8.2 Oral Anti-allergic Drugs Market Drivers
8.3 Oral Anti-allergic Drugs Market Challenges
8.4 Oral Anti-allergic Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Oral Anti-allergic Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Oral Anti-allergic Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Oral Anti-allergic Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Oral Anti-allergic Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Oral Anti-allergic Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Oral Anti-allergic Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Oral Anti-allergic Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Oral Anti-allergic Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Oral Anti-allergic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oral Anti-allergic Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oral Anti-allergic Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Oral Anti-allergic Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oral Anti-allergic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anti-allergic Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oral Anti-allergic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Oral Anti-allergic Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Oral Anti-allergic Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Oral Anti-allergic Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Oral Anti-allergic Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Oral Anti-allergic Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Oral Anti-allergic Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Oral Anti-allergic Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Oral Anti-allergic Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Oral Anti-allergic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Oral Anti-allergic Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Oral Anti-allergic Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Oral Anti-allergic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Oral Anti-allergic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Oral Anti-allergic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Oral Anti-allergic Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Oral Anti-allergic Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Oral Anti-allergic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Oral Anti-allergic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Oral Anti-allergic Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Oral Anti-allergic Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Oral Anti-allergic Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Oral Anti-allergic Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Oral Anti-allergic Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Oral Anti-allergic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Oral Anti-allergic Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Oral Anti-allergic Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Oral Anti-allergic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Oral Anti-allergic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Oral Anti-allergic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Oral Anti-allergic Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Oral Anti-allergic Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Oral Anti-allergic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Oral Anti-allergic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Oral Anti-allergic Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Oral Anti-allergic Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Oral Anti-allergic Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Oral Anti-allergic Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Oral Anti-allergic Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Oral Anti-allergic Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Oral Anti-allergic Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Oral Anti-allergic Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Oral Anti-allergic Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Oral Anti-allergic Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Oral Anti-allergic Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Oral Anti-allergic Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Oral Anti-allergic Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Oral Anti-allergic Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Oral Anti-allergic Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Oral Anti-allergic Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Oral Anti-allergic Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Oral Anti-allergic Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Oral Anti-allergic Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Oral Anti-allergic Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Oral Anti-allergic Drugs Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Johnson & Johnson Company Information
 Table 76. Johnson & Johnson Description and Business Overview
 Table 77. Johnson & Johnson Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Johnson & Johnson Oral Anti-allergic Drugs Product
 Table 79. Johnson & Johnson Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Merck Oral Anti-allergic Drugs Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Teva Company Information
 Table 86. Teva Description and Business Overview
 Table 87. Teva Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Teva Oral Anti-allergic Drugs Product
 Table 89. Teva Recent Developments/Updates
 Table 90. GlaxoSmithKline Company Information
 Table 91. GlaxoSmithKline Description and Business Overview
 Table 92. GlaxoSmithKline Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. GlaxoSmithKline Oral Anti-allergic Drugs Product
 Table 94. GlaxoSmithKline Recent Developments/Updates
 Table 95. Bayer Company Information
 Table 96. Bayer Description and Business Overview
 Table 97. Bayer Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Bayer Oral Anti-allergic Drugs Product
 Table 99. Bayer Recent Developments/Updates
 Table 100. Almirall Company Information
 Table 101. Almirall Description and Business Overview
 Table 102. Almirall Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Almirall Oral Anti-allergic Drugs Product
 Table 104. Almirall Recent Developments/Updates
 Table 105. Pfizer Company Information
 Table 106. Pfizer Description and Business Overview
 Table 107. Pfizer Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Pfizer Oral Anti-allergic Drugs Product
 Table 109. Pfizer Recent Developments/Updates
 Table 110. AstraZeneca Company Information
 Table 111. AstraZeneca Description and Business Overview
 Table 112. AstraZeneca Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. AstraZeneca Oral Anti-allergic Drugs Product
 Table 114. AstraZeneca Recent Developments/Updates
 Table 115. Sun Pharma Company Information
 Table 116. Sun Pharma Description and Business Overview
 Table 117. Sun Pharma Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Sun Pharma Oral Anti-allergic Drugs Product
 Table 119. Sun Pharma Recent Developments/Updates
 Table 120. Novartis Company Information
 Table 121. Novartis Description and Business Overview
 Table 122. Novartis Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Novartis Oral Anti-allergic Drugs Product
 Table 124. Novartis Recent Developments/Updates
 Table 125. Boehringer Ingelheim Company Information
 Table 126. Boehringer Ingelheim Description and Business Overview
 Table 127. Boehringer Ingelheim Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Boehringer Ingelheim Oral Anti-allergic Drugs Product
 Table 129. Boehringer Ingelheim Recent Developments/Updates
 Table 130. UCB Pharma Company Information
 Table 131. UCB Pharma Description and Business Overview
 Table 132. UCB Pharma Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. UCB Pharma Oral Anti-allergic Drugs Product
 Table 134. UCB Pharma Recent Developments/Updates
 Table 135. Yangtze River Pharmaceutical Group Company Information
 Table 136. Yangtze River Pharmaceutical Group Description and Business Overview
 Table 137. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Product
 Table 139. Yangtze River Pharmaceutical Group Recent Developments/Updates
 Table 140. Hainan Poly Pharm Company Information
 Table 141. Hainan Poly Pharm Description and Business Overview
 Table 142. Hainan Poly Pharm Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Hainan Poly Pharm Oral Anti-allergic Drugs Product
 Table 144. Hainan Poly Pharm Recent Developments/Updates
 Table 145. Chongqing Huapont Pharmaceutical Company Information
 Table 146. Chongqing Huapont Pharmaceutical Description and Business Overview
 Table 147. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Product
 Table 149. Chongqing Huapont Pharmaceutical Recent Developments/Updates
 Table 150. Dawnrays Pharma Company Information
 Table 151. Dawnrays Pharma Description and Business Overview
 Table 152. Dawnrays Pharma Oral Anti-allergic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Dawnrays Pharma Oral Anti-allergic Drugs Product
 Table 154. Dawnrays Pharma Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Oral Anti-allergic Drugs Distributors List
 Table 158. Oral Anti-allergic Drugs Customers List
 Table 159. Oral Anti-allergic Drugs Market Trends
 Table 160. Oral Anti-allergic Drugs Market Drivers
 Table 161. Oral Anti-allergic Drugs Market Challenges
 Table 162. Oral Anti-allergic Drugs Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oral Anti-allergic Drugs
 Figure 2. Global Oral Anti-allergic Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oral Anti-allergic Drugs Market Share by Type: 2024 & 2031
 Figure 4. Antihistamine Drugs Product Picture
 Figure 5. Allergic Mediator Release Agent Product Picture
 Figure 6. Immunosuppressant Drugs Product Picture
 Figure 7. Global Oral Anti-allergic Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Oral Anti-allergic Drugs Market Share by Application: 2024 & 2031
 Figure 9. Hospital Pharmacies
 Figure 10. Retail Pharmacies
 Figure 11. Online Pharmacies
 Figure 12. Global Oral Anti-allergic Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Oral Anti-allergic Drugs Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Oral Anti-allergic Drugs Sales (2020-2031) & (K Units)
 Figure 15. Global Oral Anti-allergic Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 16. Oral Anti-allergic Drugs Report Years Considered
 Figure 17. Oral Anti-allergic Drugs Sales Share by Manufacturers in 2024
 Figure 18. Global Oral Anti-allergic Drugs Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Oral Anti-allergic Drugs Players: Market Share by Revenue in Oral Anti-allergic Drugs in 2024
 Figure 20. Oral Anti-allergic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Oral Anti-allergic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Oral Anti-allergic Drugs Sales Market Share by Country (2020-2031)
 Figure 23. North America Oral Anti-allergic Drugs Revenue Market Share by Country (2020-2031)
 Figure 24. United States Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Oral Anti-allergic Drugs Sales Market Share by Country (2020-2031)
 Figure 27. Europe Oral Anti-allergic Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Oral Anti-allergic Drugs Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Oral Anti-allergic Drugs Revenue Market Share by Region (2020-2031)
 Figure 35. China Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Oral Anti-allergic Drugs Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Oral Anti-allergic Drugs Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Oral Anti-allergic Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Oral Anti-allergic Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Oral Anti-allergic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Oral Anti-allergic Drugs by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Oral Anti-allergic Drugs by Type (2020-2031)
 Figure 54. Global Oral Anti-allergic Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Oral Anti-allergic Drugs by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Oral Anti-allergic Drugs by Application (2020-2031)
 Figure 57. Global Oral Anti-allergic Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 58. Oral Anti-allergic Drugs Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS